Signum out-licenses SIG990 to Dermata to develop new topical treatment for

Signum out-licenses SIG990 to Dermata to develop new topical treatment for … US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a topical product to treat patients with rosacea, a … Continue reading

Posted in Flea Protection Media | Tagged , , , , , , , | Leave a comment